TUDCA modulates drug bioavailability to regulate resistance to acute ER stress in Saccharomyces cerevisiae
Molecular Biology of the Cell · 2025
DOI: 10.1091/mbc.e24-04-0147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology of the Cell, 2025. Verfasst von Sarah R Chadwick und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, The University of Western Ontario, London, Ontario N6A 5C1, Canada. Hauptthemen laut MEDLINE: Taurochenodeoxycholic Acid, Endoplasmic Reticulum Stress, Saccharomyces cerevisiae. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Cells counter accumulation of misfolded secretory proteins in the endoplasmic reticulum (ER) through activation of the Unfolded Protein Response (UPR). Small molecules termed chemical chaperones can promote protein folding to alleviate ER stress. The bile acid tauroursodeoxycholic acid (TUDCA) has been described as a chemical chaperone. While promising in models of protein folding diseases, TUDCA's mechanism of action remains unclear. Here, we found TUDCA can rescue growth of yeast treated with the ER stressor tunicamycin (Tm), even in the absence of a functional UPR. In contrast, TUDCA failed to rescue growth on other ER stressors. Nor could TUDCA attenuate chronic UPR associated with specific gene deletions or overexpression of a misfolded mutant secretory protein. Neither pretreatment with nor delayed addition of TUDCA conferred protection against Tm. Importantly, attenuation of Tm-induced toxicity required TUDCA's critical micelle forming concentration, suggesting a mechanism where TUDCA directly sequesters drugs. Indeed, in several assays, TUDCA-treated cells closely resembled cells treated with lower doses of Tm. In addition, we found TUDCA can inhibit dyes from labeling intracellular compartments. Thus, our study challenges the model of TUDCA as a chemical chaperone and suggests that TUDCA decreases drug bioavailability, allowing cells to adapt to ER stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Cell Biology, The University of Western Ontario, London, Ontario N6A 5C1, Canada.
- Department of Biochemistry, The University of Western Ontario, London, Ontario N6A 5C1, Canada.
- Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461.
- Janelia Research Campus of the Howard Hughes Medical Institute, Ashburn, VA 20147.
- Children's Health Research Institute, Lawson Health Research Institute, London, Ontario N6C 2V5, Canada.
ORCID-Profile: Matthew D Berg, Patrick Lajoie
Förderung
- NICHD NIH HHS
Zitieren
APA
Chadwick, S. R., Stack-Couture, S., Berg, M. D., Di Gregorio, S., Lung, B., Genereaux, J., Moir, R. D., Brandl, C. J., Willis, I. M., Snapp, E. L., & Lajoie, P. (2025). TUDCA modulates drug bioavailability to regulate resistance to acute ER stress in Saccharomyces cerevisiae. Molecular Biology of the Cell. https://doi.org/10.1091/mbc.e24-04-0147
Vancouver
Chadwick SR, Stack-Couture S, Berg MD, Di Gregorio S, Lung B, Genereaux J, et al. TUDCA modulates drug bioavailability to regulate resistance to acute ER stress in Saccharomyces cerevisiae. Molecular Biology of the Cell. 2025. doi:10.1091/mbc.e24-04-0147
BibTeX
@article{Chadwick2025,
author = {Chadwick, Sarah R and Stack-Couture, Samuel and Berg, Matthew D and Di Gregorio, Sonja and Lung, Bryan and Genereaux, Julie and Moir, Robyn D and Brandl, Christopher J and Willis, Ian M and Snapp, Erik L and Lajoie, Patrick},
title = {TUDCA modulates drug bioavailability to regulate resistance to acute ER stress in Saccharomyces cerevisiae},
journal = {Molecular Biology of the Cell},
year = {2025},
doi = {10.1091/mbc.e24-04-0147}
}
EUVIMED